ACE and COVID-19: Further studies should evaluate the influence of modifier genes on the CF outcomes regarding COVID-19 because the modifier genes, including the variants in the ACE gene, were previously associated with the worst lung disease and response to treatment, including the response to personalized and precision medicine [92,93,94,95,96].